Comment
doi: 10.1016/S1470-2045(17)30714-3.
Epub 2017 Sep 25.
Continued disappointments with targeted agents in first-line therapy of advanced gastric cancers
Affiliations
- PMID: 28958501
- DOI: 10.1016/S1470-2045(17)30714-3
Item in Clipboard
Comment
Continued disappointments with targeted agents in first-line therapy of advanced gastric cancers
Lancet Oncol.
2017 Nov.
No abstract available
Comment on
-
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Oncol. 2017 Nov;18(11):1467-1482. doi: 10.1016/S1470-2045(17)30566-1. Epub 2017 Sep 25. Lancet Oncol. 2017. PMID: 28958504 Free PMC article. Clinical Trial.
Similar articles
-
[Chinese expert consensus on the molecular-targeted therapy for HER-2-positive advanced gastric cancer].Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):315-9. doi: 10.3760/cma.j.issn.0253-3766.2013.04.017. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23985265 Chinese. No abstract available.
-
Advanced HER2-positive gastric cancer: current and future targeted therapies.Crit Rev Oncol Hematol. 2013 Mar;85(3):350-62. doi: 10.1016/j.critrevonc.2012.08.008. Epub 2012 Sep 26. Crit Rev Oncol Hematol. 2013. PMID: 23021388 Review.
-
Second-line chemotherapy for patients with advanced gastric cancer.Gastric Cancer. 2017 May;20(3):395-406. doi: 10.1007/s10120-017-0707-8. Epub 2017 Mar 4. Gastric Cancer. 2017. PMID: 28260227 Review.
-
Current advances in targeted therapies for metastatic gastric cancer: improving patient care.Future Oncol. 2016 Mar;12(6):839-54. doi: 10.2217/fon.15.348. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26838766 Review.
-
Targeted therapy in gastric cancer.APMIS. 2015 May;123(5):365-72. doi: 10.1111/apm.12359. Epub 2015 Feb 23. APMIS. 2015. PMID: 25706252 Review.
Cited by
-
Comprehensive landscape of gastric cancer-targeted therapy and identification of CSNK2A1 as a potential target.Heliyon. 2024 Aug 18;10(16):e36205. doi: 10.1016/j.heliyon.2024.e36205. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253198 Free PMC article.
-
Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer.Ann Surg Oncol. 2020 Oct;27(11):4250-4260. doi: 10.1245/s10434-020-08559-7. Epub 2020 Jun 6. Ann Surg Oncol. 2020. PMID: 32506192
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
